Developms a device to treat dysphagia;a condition that disables the safe swallowing of food
Phagenesis has raised €64M across 4 funding rounds from 5 investors, most recently a Series D+ round in Mar 2024. Based in Manchester Science Park Pencroft, UK; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-04 | Series D+ | €39M | Aphelion,British Patient Capital,EQT Life Sciences,Northern Gritstone,Sectoral | View deal → |
| 2013-05-01 | Series B | €15M | — | View deal → |
| 2011-10-01 | Other | €7.0M | — | View deal → |
| 2010-09-01 | Other | €2.8M | — | View deal → |
